Hemophilia is a rare and often misunderstood disease. Many people only know that it’s a blood disorder, and after that, myths and misinformation abound. So what exactly is hemophilia? Alisa Wolberg, ...

Hemophilia arises due to the deficiency or malfunction of plasma coagulation factor VIII or factor IX. [iStockphoto] Haemophilia, a rare genetic blood disorder primarily affecting males, is a ...

Haemophilia B constitutes a severe rare genetic bleeding condition which interferes strongly with blood clotting mechanisms. People who receive early diagnosis and receive effective treatment while ...

Hemophilia B, also known as Christmas disease, is a bleeding disorder. Its characteristic feature is a deficiency of clotting factor IX. This is a protein present in the blood that helps with ...

Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment. Despite ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

At AMCP Nexus, Evernorth's Aimee Tharaldson, PharmD, provided an overview of which medications the FDA has approved in 2023 and what’s to come in nononcology areas over the next 5 years, including new ...

The medical cost burden for patients with severe chronic diseases requiring treatments such as hemodialysis for chronic renal ...

Please enable JavaScript to read this content. Hemophilia arises due to the deficiency or malfunction of plasma coagulation factor VIII or factor IX. [iStockphoto ...